Mammaglobin B expression in human endometrial cancer

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Mammaglobin B (MGB-2), an uteroglobin family member, shows differential expression in ovarian cancer.
• Endometrial cancer diagnosis and grading are critical for treatment decisions.

Purpose of the Study:

• To evaluate Mammaglobin B (MGB-2) as a potential biomarker for endometrial cancer.
• To quantify and compare MGB-2 expression in endometrioid endometrial cancer (EEC) of varying differentiation grades.

Main Methods:

• Real-time polymerase chain reaction (PCR) to assess MGB-2 messenger RNA (mRNA) levels.
• Immunohistochemistry (IHC) to evaluate MGB-2 protein expression.
• Analysis of 70 endometrial tissue samples (50 EEC, 20 normal endometria).

Main Results:

• High MGB-2 gene expression was observed in 91% of G1 and 94% of G2 EEC, significantly higher than in normal endometria (NEC).
• MGB-2 expression was significantly lower in G3 EEC compared to G1 and G2 EEC (P < 0.001).
• MGB-2 protein was detected in 86% of EEC tissues, with minimal expression in most normal endometrial controls.

Conclusions:

• MGB-2 is highly expressed in endometrioid endometrial cancer (EEC), especially in well- and moderately differentiated tumors.
• MGB-2 demonstrates potential as a novel molecular biomarker for EEC.
• Differential expression across grades suggests MGB-2's utility in assessing tumor differentiation.